VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase I study of bortezomib in refractory or relapsed acute leukemias.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase I study of bortezomib in refractory or relapsed acute leukemias.
Phase I study of bortezomib in refractory or relapsed acute leukemias. Clin Cancer Res. 2004 May 15; 10(10):3371-6.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Antineoplastic Agents
Apoptosis
Boronic Acids
Bortezomib
Dose-Response Relationship, Drug
Humans
Leukemia, Myeloid, Acute
Maximum Tolerated Dose
Middle Aged
Models, Chemical
Myelodysplastic Syndromes
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Proteasome Endopeptidase Complex
Proteasome Inhibitors
Pyrazines
Recurrence
Time Factors
authors with profiles
HAGOP M KANTARJIAN
JORGE E CORTES
GUILLERMO GARCIA-MANERO